Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Perspectives

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package

      
Total article views   HTML views PDF downloads Totals
10,196 Dovepress* 9,025+ 2,038 11,063
PubMed Central* 1,171 382 1,553
Totals 10,196 2,420 12,616
*Since 6 December 2012
+Since July 2016

View citations on PubMed Central and Google Scholar